These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 12162911)

  • 21. Prolonged molecular remission after arsenic trioxide and all-trans retinoic acid for acute promyelocytic leukemia relapsed after allogeneic stem cell transplantation.
    Grigg A; Kimber R; Szer J
    Leukemia; 2003 Sep; 17(9):1916-7; author reply 1918. PubMed ID: 12970801
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute promyelocytic leukemia as a paradigm for targeted therapy.
    Tallman MS
    Semin Hematol; 2004 Apr; 41(2 Suppl 4):27-32. PubMed ID: 15190513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute promyelocytic leukemia: recent advances in diagnosis and management.
    Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
    Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents.
    Zhu J; Guo WM; Yao YY; Zhao WL; Pan L; Cai X; Ju B; Sun GL; Wang HL; Chen SJ; Chen GQ; Caen J; Chen Z; Wang ZY
    Leukemia; 1999 Jul; 13(7):1062-70. PubMed ID: 10400422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extramedullary relapse in a patient with acute promyelocytic leukemia: successful treatment with arsenic trioxide, all-trans retinoic acid and gemtuzumab ozogamicin therapies.
    Tsimberidou AM; Estey E; Whitman GJ; Dryden MJ; Ratnam S; Pierce S; Faderl S; Giles F; Kantarjian HM; Garcia-Manero G
    Leuk Res; 2004 Sep; 28(9):991-4. PubMed ID: 15234578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed recovery of normal hematopoiesis in arsenic trioxide treatment of acute promyelocytic leukemia: a comparison to all-trans retinoic acid treatment.
    Shinjo K; Takeshita A; Sahara N; Kobayashi M; Nakamura S; Shigeno K; Naito K; Maekawa M; Ohnishi K; Ohno R
    Intern Med; 2005 Aug; 44(8):818-24. PubMed ID: 16157979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia.
    Soignet SL
    Oncologist; 2001; 6 Suppl 2():11-6. PubMed ID: 11331435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies for the treatment of acute promyelocytic leukemia.
    Frankfurt O; Tallman MS
    J Natl Compr Canc Netw; 2006 Jan; 4(1):37-50. PubMed ID: 16403403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent acute myopericarditis without effusion during ATRA induction and ATO salvage of APL: a variant form of the differentiation syndrome?
    Vassilakopoulos TP; Asimakopoulos JV; Plata E; Kelepesis G; Petevi K; Koutsi C; Papageorgiou L; Tsaftaridis P; Angelopoulou MK; Konstantopoulos K; Meletis J
    Leuk Lymphoma; 2017 Jul; 58(7):1743-1746. PubMed ID: 27919176
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of acute promyelocytic leukemia without cytotoxic chemotherapy.
    Park JH; Tallman MS
    Oncology (Williston Park); 2011 Jul; 25(8):733-41. PubMed ID: 21874835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An analysis of the therapeutic effects and reactions in treating acute promyelocytic leukemia with intravenous arsenic trioxide or all-trans retinoic acid].
    Zhang X; Yang L; Qiao Z
    Zhonghua Nei Ke Za Zhi; 1999 Feb; 38(2):113-5. PubMed ID: 11798639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged molecular remission in advanced acute promyelocytic leukaemia after treatment with gemtuzumab ozogamicin (Mylotarg CMA-676).
    Petti MC; Pinazzi MB; Diverio D; Romano A; Petrucci MT; De Santis S; Meloni G; Tafuri A; Mandelli F; Lo Coco F
    Br J Haematol; 2001 Oct; 115(1):63-5. PubMed ID: 11722411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of relapsed acute promyelocytic leukemia by arsenic trioxide in Iran.
    Alimoghaddam K; Ghavamzadeh A; Jahani M; Mousavi A; Iravani M; Rostami S; Ghaffari H; Hosseini R; Jalili M
    Arch Iran Med; 2011 May; 14(3):167-9. PubMed ID: 21529103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in the treatment of acute promyelocytic leukemia: optimization and obstruction.
    Li J; Zhu H; Hu J; Mi J; Chen S; Chen Z; Wang Z
    Int J Hematol; 2014 Jul; 100(1):38-50. PubMed ID: 24938378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Arsenic trioxide treatment in a patient with recurrent acute promyelocytic leukemia (APL)].
    Moreno Tejero ML; Lassaletta Atienza A; García Salido A; Sevilla Navarro J; Madero López L
    An Pediatr (Barc); 2010 Jul; 73(1):39-41. PubMed ID: 20605542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute promyelocytic leukemia: from highly fatal to highly curable.
    Wang ZY; Chen Z
    Blood; 2008 Mar; 111(5):2505-15. PubMed ID: 18299451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute promyelocytic leukemia with isochromosome 17q and cryptic PML-RARA successfully treated with all-trans retinoic acid and arsenic trioxide.
    Shepshelovich D; Oniashvili N; Parnes D; Klein A; Muchtar E; Yeshaya J; Aviram A; Rabizadeh E; Raanani P
    Cancer Genet; 2015 Nov; 208(11):575-9. PubMed ID: 26471811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATRA plus arsenic gets another "A" in APL.
    Park JH
    Blood; 2012 Aug; 120(8):1535-6. PubMed ID: 22918418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gemtuzumab Ozogamicin Followed by Unrelated Cord Blood Transplantation With Reduced-intensity Conditioning for a Child With Refractory Acute Promyelocytic Leukemia.
    Yamada Y; Osumi T; Kato M; Shioda Y; Kiyotani C; Terashima K; Hayakawa A; Iijima-Yamashita Y; Horibe K; Matsumoto K; Tomizawa D
    J Pediatr Hematol Oncol; 2022 May; 44(4):178-180. PubMed ID: 35091516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to manage acute promyelocytic leukemia.
    Mi JQ; Li JM; Shen ZX; Chen SJ; Chen Z
    Leukemia; 2012 Aug; 26(8):1743-51. PubMed ID: 22422168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.